CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 108 filers reported holding CHEMOCENTRYX INC in Q4 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,600,000 | +264.9% | 360,036 | +75.0% | 0.00% | +100.0% |
| Q2 2022 | $5,097,000 | -32.6% | 205,718 | -31.8% | 0.00% | 0.0% |
| Q1 2022 | $7,558,000 | +170.0% | 301,522 | +292.1% | 0.00% | – |
| Q4 2021 | $2,799,000 | +130.2% | 76,895 | +8.2% | 0.00% | – |
| Q3 2021 | $1,216,000 | +243.5% | 71,085 | +168.3% | 0.00% | – |
| Q2 2021 | $354,000 | -95.3% | 26,494 | -82.1% | 0.00% | -100.0% |
| Q1 2021 | $7,584,000 | -4.5% | 148,017 | +15.4% | 0.00% | 0.0% |
| Q4 2020 | $7,940,000 | +20.3% | 128,224 | +6.5% | 0.00% | 0.0% |
| Q3 2020 | $6,598,000 | +111.8% | 120,396 | +122.4% | 0.00% | – |
| Q2 2020 | $3,115,000 | +55.6% | 54,145 | +8.6% | 0.00% | – |
| Q1 2020 | $2,002,000 | +33.2% | 49,853 | +31.2% | 0.00% | – |
| Q4 2019 | $1,503,000 | +182.0% | 37,995 | -51.7% | 0.00% | – |
| Q3 2019 | $533,000 | -42.3% | 78,610 | -20.8% | 0.00% | – |
| Q2 2019 | $923,000 | -28.4% | 99,304 | +7.0% | 0.00% | – |
| Q1 2019 | $1,289,000 | +26.2% | 92,817 | -0.9% | 0.00% | – |
| Q4 2018 | $1,021,000 | -20.7% | 93,623 | -8.0% | 0.00% | – |
| Q3 2018 | $1,287,000 | -4.1% | 101,800 | -0.1% | 0.00% | – |
| Q2 2018 | $1,342,000 | +15.9% | 101,871 | +19.7% | 0.00% | – |
| Q1 2018 | $1,158,000 | +113.3% | 85,137 | -6.7% | 0.00% | – |
| Q4 2017 | $543,000 | +28.1% | 91,231 | +59.8% | 0.00% | – |
| Q3 2017 | $424,000 | -1.2% | 57,091 | +24.5% | 0.00% | – |
| Q2 2017 | $429,000 | -47.9% | 45,868 | -59.5% | 0.00% | – |
| Q1 2017 | $824,000 | -29.7% | 113,121 | -28.6% | 0.00% | – |
| Q4 2016 | $1,172,000 | -39.6% | 158,387 | -50.7% | 0.00% | – |
| Q3 2016 | $1,940,000 | -2.1% | 321,207 | -27.2% | 0.00% | – |
| Q2 2016 | $1,981,000 | +705.3% | 441,095 | +345.6% | 0.00% | – |
| Q1 2016 | $246,000 | -23.8% | 98,989 | +148.4% | 0.00% | – |
| Q4 2015 | $323,000 | +466.7% | 39,852 | +324.0% | 0.00% | – |
| Q3 2015 | $57,000 | -25.0% | 9,400 | +0.9% | 0.00% | – |
| Q2 2015 | $76,000 | +7.0% | 9,312 | -0.5% | 0.00% | – |
| Q1 2015 | $71,000 | +12.7% | 9,362 | +0.7% | 0.00% | – |
| Q4 2014 | $63,000 | +50.0% | 9,300 | 0.0% | 0.00% | – |
| Q3 2014 | $42,000 | -80.3% | 9,300 | -74.5% | 0.00% | – |
| Q2 2014 | $213,000 | -17.1% | 36,446 | -6.0% | 0.00% | – |
| Q1 2014 | $257,000 | -8.9% | 38,755 | -20.5% | 0.00% | – |
| Q4 2013 | $282,000 | -5.7% | 48,742 | -9.2% | 0.00% | – |
| Q3 2013 | $299,000 | -69.7% | 53,676 | -23.1% | 0.00% | – |
| Q2 2013 | $986,000 | – | 69,787 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |